Click for best price
Blood Cancer Therapeutics Market Size, Share 2023
Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.
This report aims to provide a comprehensive presentation of the global market for Blood Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Cancer Therapeutics. This report contains market size and forecasts of Blood Cancer Therapeutics in global, including the following market information:
Global Blood Cancer Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Blood Cancer Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Chronic Myeloid Leukemia (CML) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blood Cancer Therapeutics include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Roche, Novartis, Boehringer Ingelheim, Pfizer and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Blood Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Cancer Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Blood Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
Chronic Myeloid Leukemia (CML)
Acute Lymphocytic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
Acute Myeloid Leukemia (AML)
Global Blood Cancer Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Blood Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Global Blood Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Blood Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Blood Cancer Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
AstraZeneca
Bristol-Myers Squibb
GlaxoSmithKline
Roche
Novartis
Boehringer Ingelheim
Pfizer
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Cancer Therapeutics, market overview.
Chapter 2: Global Blood Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Blood Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Blood Cancer Therapeutics Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Blood Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Cancer Therapeutics Overall Market Size
2.1 Global Blood Cancer Therapeutics Market Size: 2022 VS 2029
2.2 Global Blood Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Blood Cancer Therapeutics Players in Global Market
3.2 Top Global Blood Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Blood Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Blood Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Blood Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blood Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Blood Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Blood Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Blood Cancer Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Chronic Myeloid Leukemia (CML)
4.1.3 Acute Lymphocytic Leukemia (ALL)
4.1.4 Chronic Lymphocytic Leukemia (CLL)
4.1.5 Acute Myeloid Leukemia (AML)
4.2 By Type - Global Blood Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Blood Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Blood Cancer Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Blood Cancer Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Blood Cancer Therapeutics Market Size, 2022 & 2029
5.1.2 Cancer Research Centers
5.1.3 Cancer Hospital
5.1.4 Surgical Centers
5.1.5 Clinics
5.2 By Application - Global Blood Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Blood Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Blood Cancer Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Blood Cancer Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Blood Cancer Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Blood Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Blood Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Blood Cancer Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Blood Cancer Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Blood Cancer Therapeutics Revenue, 2018-2029
6.3.2 US Blood Cancer Therapeutics Market Size, 2018-2029
6.3.3 Canada Blood Cancer Therapeutics Market Size, 2018-2029
6.3.4 Mexico Blood Cancer Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Blood Cancer Therapeutics Revenue, 2018-2029
6.4.2 Germany Blood Cancer Therapeutics Market Size, 2018-2029
6.4.3 France Blood Cancer Therapeutics Market Size, 2018-2029
6.4.4 U.K. Blood Cancer Therapeutics Market Size, 2018-2029
6.4.5 Italy Blood Cancer Therapeutics Market Size, 2018-2029
6.4.6 Russia Blood Cancer Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Blood Cancer Therapeutics Market Size, 2018-2029
6.4.8 Benelux Blood Cancer Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Blood Cancer Therapeutics Revenue, 2018-2029
6.5.2 China Blood Cancer Therapeutics Market Size, 2018-2029
6.5.3 Japan Blood Cancer Therapeutics Market Size, 2018-2029
6.5.4 South Korea Blood Cancer Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Blood Cancer Therapeutics Market Size, 2018-2029
6.5.6 India Blood Cancer Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Blood Cancer Therapeutics Revenue, 2018-2029
6.6.2 Brazil Blood Cancer Therapeutics Market Size, 2018-2029
6.6.3 Argentina Blood Cancer Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Blood Cancer Therapeutics Revenue, 2018-2029
6.7.2 Turkey Blood Cancer Therapeutics Market Size, 2018-2029
6.7.3 Israel Blood Cancer Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Blood Cancer Therapeutics Market Size, 2018-2029
6.7.5 UAE Blood Cancer Therapeutics Market Size, 2018-2029
7 Blood Cancer Therapeutics Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Blood Cancer Therapeutics Major Product Offerings
7.1.4 AbbVie Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Blood Cancer Therapeutics Major Product Offerings
7.2.4 AstraZeneca Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Blood Cancer Therapeutics Major Product Offerings
7.3.4 Bristol-Myers Squibb Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Blood Cancer Therapeutics Major Product Offerings
7.4.4 GlaxoSmithKline Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Blood Cancer Therapeutics Major Product Offerings
7.5.4 Roche Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Blood Cancer Therapeutics Major Product Offerings
7.6.4 Novartis Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Blood Cancer Therapeutics Major Product Offerings
7.7.4 Boehringer Ingelheim Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Blood Cancer Therapeutics Major Product Offerings
7.8.4 Pfizer Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Blood Cancer Therapeutics Major Product Offerings
7.9.4 Sanofi Blood Cancer Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Blood Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Blood Cancer Therapeutics Market Drivers in Global Market
Table 3. Blood Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Blood Cancer Therapeutics in Global Market
Table 5. Top Blood Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Blood Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Blood Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Blood Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Blood Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blood Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Blood Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Blood Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Blood Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Blood Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Blood Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Blood Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Blood Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Blood Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Blood Cancer Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Blood Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Blood Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Blood Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Blood Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Blood Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. AbbVie Company Summary
Table 31. AbbVie Blood Cancer Therapeutics Product Offerings
Table 32. AbbVie Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Blood Cancer Therapeutics Product Offerings
Table 36. AstraZeneca Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Blood Cancer Therapeutics Product Offerings
Table 40. Bristol-Myers Squibb Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Blood Cancer Therapeutics Product Offerings
Table 44. GlaxoSmithKline Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Blood Cancer Therapeutics Product Offerings
Table 48. Roche Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Blood Cancer Therapeutics Product Offerings
Table 52. Novartis Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Blood Cancer Therapeutics Product Offerings
Table 56. Boehringer Ingelheim Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Blood Cancer Therapeutics Product Offerings
Table 60. Pfizer Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Blood Cancer Therapeutics Product Offerings
Table 64. Sanofi Blood Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Blood Cancer Therapeutics Segment by Type in 2022
Figure 2. Blood Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Blood Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Blood Cancer Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Blood Cancer Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Blood Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Blood Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Blood Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Blood Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Blood Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. AbbVie Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Boehringer Ingelheim Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
